Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:52 AM
Ignite Modification Date:
2025-12-25 @ 4:52 AM
NCT ID:
NCT00060918
Eligibility Criteria:
Inclusion criteria:
* Patients at screening must be insulin producing Type II diabetics (C peptide positive).
* Must have a history of mild to moderate hypertension (140-179 systolic; 90-1-9 diastolic).
* Must be on stable regimen of ACE (angiotensin converting enzyme) / ARB (angiotensin receptor blocker) treatment alone or in combination with other treatments.
* Patient''s laboratory result for HbA1c must be 6.5 - 8.5 (drug treated) or 6.5 - 7.5 (diet alone).
* Must be on a stable antidiabetic regimen (drug treated or diet alone).
Exclusion criteria:
* Patients using beta-blocker therapy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
80 Years
Study:
NCT00060918
Study Brief:
Protocol Section:
NCT00060918